Non-invasive prenatal diagnosis — toward a new horizon

Marleen R Susman, David J Amor and Jane L Halliday
Med J Aust 2009; 191 (7): . || doi: 10.5694/j.1326-5377.2009.tb02865.x
Published online: 5 October 2009

To the Editor: The introduction of non-invasive prenatal testing will revolutionise the practice of prenatal diagnosis. One of the many potential applications of non-invasive prenatal diagnosis (NIPD) is to determine fetal RHD status in pregnant Rhesus (Rh) D-negative women, and the feasibility of such testing was aptly demonstrated by Hyland and colleagues1 and commented on by Cole and Savoia.2 It is clear that once the technical problems of indeterminate results and gene variants are resolved, NIPD for RHD status will have improved clinical utility over current invasive testing, thus reducing the need for invasive procedures and prophylactic treatment of all RhD-negative women.

  • Marleen R Susman
  • David J Amor
  • Jane L Halliday

  • Murdoch Childrens Research Institute, Melbourne, VIC.



remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.